U.S. patent application number 10/056534 was filed with the patent office on 2002-07-18 for graft fixation device combination.
Invention is credited to Bowman, Steven M..
Application Number | 20020095157 10/056534 |
Document ID | / |
Family ID | 22005043 |
Filed Date | 2002-07-18 |
United States Patent
Application |
20020095157 |
Kind Code |
A1 |
Bowman, Steven M. |
July 18, 2002 |
Graft fixation device combination
Abstract
A graft fixation device combination. The device is useful for
affixing a tissue graft to a bone or other body surface. The
combination has a fixation device having two implantation members
connected by a connecting member. The implantation members have
longitudinal passageways therethrough. The combination also has an
insertion member in engagement with the distal end of each
implantation member.
Inventors: |
Bowman, Steven M.;
(Sherborn, MA) |
Correspondence
Address: |
AUDLEY A. CIAMPORCERO JR.
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933-7003
US
|
Family ID: |
22005043 |
Appl. No.: |
10/056534 |
Filed: |
January 24, 2002 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10056534 |
Jan 24, 2002 |
|
|
|
09535183 |
Mar 27, 2000 |
|
|
|
10056534 |
Jan 24, 2002 |
|
|
|
09360367 |
Jul 23, 1999 |
|
|
|
6179840 |
|
|
|
|
Current U.S.
Class: |
606/75 |
Current CPC
Class: |
A61B 17/0401 20130101;
A61F 2002/0858 20130101; A61B 2017/0414 20130101; A61B 2017/0646
20130101; A61B 17/92 20130101; A61B 2017/0409 20130101; A61F 2/0805
20130101; A61B 2017/0608 20130101; A61B 2017/0412 20130101; A61F
2/2846 20130101; A61B 17/068 20130101; A61B 2017/06057 20130101;
A61B 17/0642 20130101; A61B 17/00234 20130101; A61B 2017/0445
20130101; A61B 2017/00783 20130101; A61B 2017/00243 20130101; A61B
2017/0406 20130101; A61B 2017/00004 20130101; A61B 2017/0419
20130101; A61B 2017/0647 20130101; A61B 2017/0427 20130101; A61B
17/06 20130101; A61F 2002/0888 20130101; A61F 2/0811 20130101 |
Class at
Publication: |
606/75 |
International
Class: |
A61B 017/58 |
Claims
I claim:
1. A graft fixation device, comprising: an implantation member,
said implantation member having a longitudinal axis, a proximal
end, a distal end, an outer surface, and a longitudinal passage
therethrough; at least one graft retention member, the retention
member having a first section extending from the proximal end of
the implantation member, and a second section angulated with
respect to first section for engaging a graft.
2. The device of claim 1, wherein the implantation member has a
series of ridges extending from the outer surface.
3. The device of claim 1, wherein the retention member comprises a
rod member.
4. The device of claim 3, wherein the retention member has an oval
cross-section.
5. The device of claim 1, additionally comprising a frustoconical
insertion member extending from the distal end of the implantation
member, said insertion member having a proximal end, a distal end
and an axial passage therethrough.
6. The device of claim 1, wherein the implantation member has a
cylindrical configuration.
7. The device of claim 5 wherein the insertion member comprises a
bioabsorbable material selected from the group consisting of
polylactic acid, polyglycolic acid, polycaprolactone, tricalcium
phosphate, calcium phosphate, tetracalcium phosphate and
hydroxyapatite, and copolymers, mixtures and blends thereof.
8. The device of claim 5 wherein the insertion member comprises a
biocompatible material selected from the group consisting of
titanium, stainless steel, ceramic, Delrin, and Nitinol.
9. The device of claim 1 wherein the fixation device comprises a
bioabsorbable polymer.
10. The device of claim 1 comprising four retention members.
11. The device of claim 1 comprising two retention members.
Description
[0001] This is a Continuation-in-Part application of
commonly-assigned, copending U.S. patent applications Ser. No.
09/535,183, filed on Mar. 27, 2000, which is a Continuation-In-Part
application of commonly assigned copending U.S. patent application
Ser. No. 09/360,367 filed on Jul. 23, 1999, now U.S. Pat. No.
6,179,840, which is incorporated by reference.
TECHNICAL FIELD
[0002] The field of art to which this invention relates is surgical
fastening devices, in particular, surgical fastening devices for
fixating tissue grafts to bone.
BACKGROUND OF THE INVENTION
[0003] The medical technology associated with tissue engineering
has advanced at a rapid pace. In particular, it is now known to
harvest cells from the human body, for example, chondrocytes and
fibrochrondrocytes from the knee joint. These autologous cells are
then cultured in a laboratory environment on a bioabsorbable
matrix. The matrix will typically have a shape substantially
similar to the tissue section which needs to be replaced. After a
sufficient period of time in an appropriate culture medium at the
proper environmental conditions, the harvested cells will grow on
the matrix to form an implantable section of tissue having
substantially the same physical configuration as the section of
tissue which needs to be replaced in the patient. Such a
tissue-engineered construct, consisting of cells on the matrix (or,
alternatively, consisting of a matrix alone without cells), is then
affixed to the bone site using conventionally known surgical
fasteners including sutures, periosteal coverings, or fibrin
glue.
[0004] The advantages of tissue engineering are many, not the least
of which is, for example, that it is now possible to replace
cartilage with living cartilage tissue. In addition, the likelihood
of rejection of the tissue implant is minimized since the cartilage
tissue which has been grown in-vitro is identical to the autologous
cartilage of the patient.
[0005] Although existing matrix fixation devices are adequate for
their intended use, there are also some disadvantages attendant
with their use. First of all these fixation devices are generic in
the sense that they are not specifically designed for matrix
fixation to bone or soft tissue, but can be used for a variety of
surgical procedures. Other disadvantages include the difficulty in
using many of these devices in a minimally invasive arthroscopic
procedure. Additional disadvantages include the difficulty and
surgical challenge of harvesting a piece of periosteum for use as a
periosteal flap, the significant patient morbidity associated with
such harvesting, and the difficulty in suturing such a thin,
compliant material to surrounding tissue.
[0006] Accordingly, there is a need in this art for novel fixation
devices that will effectively affix a matrix of tissue-engineered
tissue to a bone or other anchoring site so that the tissue may
continue to grow and regenerate in the patient's body.
DISCLOSURE OF THE INVENTION
[0007] Therefore, it is an object of the present invention to
provide a fixation device that effectively fixates a
tissue-engineered matrix to a bone or other anchoring site, thereby
enabling the implanted matrix to remain in place while the tissue
continues to grow and regenerate.
[0008] It is a further object of the present invention to provide
such a device for fixating a matrix to a bone site which is easily
installed using an arthroscopic procedure or an open procedure.
[0009] It is yet a further object of the present invention to
provide such a device for fixating a matrix to a bone site which
does not require sutures or suture knot tying.
[0010] It is still yet a further object of the present invention to
provide a surgical method for fixating a matrix utilizing such a
device in a location within a patient's body.
[0011] Accordingly, a graft fixation device is disclosed. The graft
fixation device has first and second implantation members. The
members are elongated and preferably have a cylindrical
configuration. The members also have distal ends, proximal ends,
and longitudinal axes. There are longitudinal passages extending
through the entire length of each implantation member. The members
have outer surfaces. The implantation members are connected to each
other by a rod member having first and second ends and a central
section. The first end of the rod member extends from the proximal
end of the first implantation member and the second end of the rod
member extends from the proximal end of the second implantation
member. The rod member is preferably relatively rigid and may be
configured to have a variety of geometric shapes, for example, an
inverted "U" shape. However, the rod member may also be flexible.
The rod member maintains the implantation members at a relatively
fixed distance from each other. The central section of the rod
member is designed to engage a section of a tissue-engineered
matrix implant. In a preferred embodiment, the implantation members
have a series of ridges extending out from the outer surfaces of
the implantation members to assist in preventing withdrawal from a
bone site or other anchoring site after the implantation members
are implanted into previously-created bore holes.
[0012] Yet another aspect of the present invention is a method of
using the graft fixation device of the present invention to affix a
matrix containing tissue-engineered tissue to a bone.
[0013] Still yet another aspect of the present invention is a graft
fixation device combination which is the combination of a fixation
device and an insertion device. The fixation device has a first
implantation member. The implantation member has a longitudinal
axis, a proximal end, a distal end, an outer surface, and a
longitudinal passage therethrough. The fixation device also has a
second implantation member. The second implantation member has a
longitudinal axis, a proximal end, a distal end, an outer surface,
and a longitudinal passage therethrough. Each implantation member
has a proximal annular face on its proximal end surrounding the
longitudinal passages. There is a connecting member connecting the
first and second implantation members. The connecting member has a
central section, a first end extending from the first implantation
member and a second end extending from the second implantation
member.
[0014] There are a pair of insertion devices. Each insertion device
is a member having a proximal end, a distal tapered end and a
longitudinal passage therethrough. The distal end of each
implantation member is in engagement with the proximal end of an
insertion device. Optionally an insertion device is mounted to the
distal end of an implantation member.
[0015] Another aspect of the present invention is a graft retention
device. The device has a single implantation member. The
implantation member has a longitudinal axis, a proximal end, a
distal end, an outer surface, and a longitudinal passage
therethrough. The device has at least one graft retention member.
The retention member has a first section extending from the
proximal end of the implantation member, and a second section
angulated with respect to first section for engaging a graft.
Optionally, an insertion member is mounted to the distal end of the
implantation member.
[0016] These and other features and advantages of the present
invention will become more apparent from the following description
and accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] FIG. 1 is a perspective view of a graft fixation device of
the present invention.
[0018] FIG. 2 is a cross-sectional view of the graft fixation
device of FIG. 1 taken along view line 2-2.
[0019] FIGS. 3-6 illustrate a surgical procedure for affixing a
matrix to bone using the graft fixation device of the present
invention.
[0020] FIG. 7 is an illustration of a graft fixation device of the
present invention after the implantation members have been
implanted in bore holes in bone illustrating the device affixing a
matrix securely to the surface of a bone.
[0021] FIG. 8 is a cross-sectional view of the graft fixation
device of FIG. 7 implanted in bone, and taken along View Line
8-8.
[0022] FIG. 9 is an alternative embodiment of a graft fixation
device of the present invention having two connecting members.
[0023] FIG. 10 is a perspective view of an instrument useful for
making bore holes in bone into which the implantable members of the
graft fixation devices of the present invention may be
emplaced.
[0024] FIG. 11 is a perspective view of an instrument useful for
implanting the device of the present invention into bore holes made
in bone.
[0025] FIG. 12 is a view of a tissue engineered matrix secured to a
bone with several graft fixation devices of the present
invention.
[0026] FIG. 13 is a perspective view of an alternate embodiment of
a graft fixation device of the present invention.
[0027] FIG. 14 is a side view of the graft fixation device of FIG.
13.
[0028] FIG. 15 is an end view of the graft fixation device of FIG.
14.
[0029] FIG. 16 is a cross-sectional view of the graft fixation
device of FIG. 14, taken along View-Line 16-16.
[0030] FIG. 17 is a cross-sectional view of the tissue retention
member of the graft fixation device of FIG. 14, taken along
View-Line 17-17.
[0031] FIG. 18 is a perspective view of an insertion member useful
to insert a graft fixation member of the present invention.
[0032] FIG. 19 is an exploded perspective view of an insertion
instrument, a graft fixation device, and two insertion members.
[0033] FIG. 20 is a side view of the distal end of the insertion
instrument, a graft fixation device, and insertion members engaged
in bone, prior to removal of the insertion device.
[0034] FIG. 21 is a cross-sectional view taken along View-Line
21-21 of FIG. 20 of the prong of the insertion instrument, and a
section of the retention member engaged in a longitudinal groove of
the prong.
[0035] FIG. 22 is an exploded perspective view of the distal end of
an insertion instrument of the present invention, illustrating a
removable distal end assembly for creating bore holes in bone for
receiving the fixation devices of the present invention, wherein
the assembly has an end member and pins.
[0036] FIG. 23 is a cross-section of the assembly end member of
FIG. 22, taken along View-Line 23.
[0037] FIG. 24 is a perspective view of the assembly end of FIG.
22, completely assembled and ready for use.
[0038] FIG. 25 is a cross-sectional view of the end assembly of
FIG. 24, taken along View-Line 25-25.
[0039] FIG. 26 is an exploded perspective view of an insertion
instrument of the present invention having a removable distal end
assembly useful for inserting the graft retention members of the
present invention into bore holes in a bone, having an end assembly
member and two pins; when used with insertion members, the
instrument can be used to emplace the fixation devices directly
into bone without first forming bone bore holes.
[0040] FIG. 27 is a cross-sectional view of the end assembly member
of FIG. 26.
[0041] FIG. 28 is a perspective view of the distal end of the
insertion instrument of FIG. 26, having the end assembly member and
prongs fully assembled and mounted.
[0042] FIG. 29 is a cross-sectional view of the distal end of the
insertion instrument of FIG. 28 take along View-Line 29-29.
[0043] FIG. 30 is a cross-sectional view of the instrument of FIG.
29 taken along View-Line 30-30.
[0044] FIG. 31 illustrates a fixation device of the present member
having an insertion member molded into the distal end of each
implantation member.
[0045] FIG. 32 is a cross-sectional view of the fixation device of
FIG. 31.
[0046] FIG. 33 is a perspective view of a graft fixation device of
the present invention having an single implantation member.
[0047] FIG. 34 is a top view of the graft fixation member of FIG.
33.
[0048] FIG. 35 is a cross-sectional view of the graft fixation
member of FIG. 33.
[0049] FIG. 36 is a perspective view of an alternate embodiment of
the graft fixation member of FIG. 33 having four retention
members.
[0050] FIG. 37 is a top view of the graft fixation member of FIG.
36.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0051] The graft fixation devices of the present invention can be
made from conventional bio-compatible materials, including
absorbable and non-absorbable materials, as well as biodegradable
materials. The non-absorbable materials which can be utilized
include conventional biocompatible materials such as stainless
steel, polyethylene, Teflon, Nitinol, non-absorbable polymers,
other bio-compatible metals, ceramics, combinations thereof and the
like. The absorbable materials which can be used to manufacture the
graft fixation devices of the present invention will typically
include those conventional bioabsorbable or bioresorbable materials
known in this art which can be effectively molded or machined. The
bio-absorbable and bio-resorbable materials include polylactic
acid, polydioxanone, polycaprolactone, polyglycolic acid,
polygalactic acid, other known biocompatible bioabsorbable and
bioresorbable polymers, ceramics, composites, combinations thereof
and the like and equivalents thereof.
[0052] Referring now to FIGS. 1-2, a preferred embodiment of a
graft fixation device 10 of the present invention is illustrated.
The graft fixation device 10 is seen to have implantation members
20. The implantation members 20 are seen to be elongated members,
preferably having a substantially cylindrical shape. The members 20
may have other geometric shapes including conical, pyramidal,
polygonal, cubic, spherical, etc. The implantation members 20 are
seen to have distal ends 22 and proximal ends 24. Each implantation
member 20 is seen to have an outer surface 28 and a longitudinal
axis 29. Each member 20 is also seen to have longitudinal passage
35 extending therethrough. The implantation members 20 are also
seen to have optional frustoconical ends 30, and proximal endface
surfaces 32. Although it is preferred that endface surfaces 32 be
flat, endface surface 32 may also be angled, concave, convex, etc.
Endface surface 32 is seen to have central circular opening 36 in
communication with passage 35. Preferably, central opening 36 will
have a circular cross-section, but it may have other geometric
cross-sections as well including elliptical, polygonal, square,
rectangular, combinations thereof and the like. Members 20 are also
seen to have distal end face surfaces 37 having circular openings
38 in communication with passages 35. As shown with the optional
frustoconical end 30, the annular end face surface 37 is of de
minimis thickness around opening 38, however this thickness would
increase in the absence of a frustoconical end. Also seen to extend
out from the surface 28 of member 20 are a series of optional
projections 40 having tissue engagement edges 44. Without the
projections 40, the surface 28 of the member 20 will be smooth.
[0053] The device 10 is seen to have graft retention member 50
connecting the implantation members 20. Retention member 50 is seen
to be a rod-like member having first end 52, second end 54 and
central section 55. First end 52 is seen to extend from proximal
endface surface 32 of the first member 20 while end 54 is seen to
extend up from the proximal endface surface 32 of the other member
20. The ends 54 and 52 of retention member 50 may also if desired
extend from or be mounted to any section of outer surface 28. The
connecting member 50 is seen to be preferably bent or shaped into
three segments including top segment 55 and leg segments 56. The
top segment 55 is seen to be substantially perpendicular to the leg
segments 56. Although it is preferred that connecting member 50
have an inverted "U" configuration, the connecting member 50 may
have other geometric configurations including semicircular, arced,
curved, triangular, polygonal, U-shaped, and the like and
combinations thereof. The ends 52 and 54 of connecting member 50
may be permanently affixed to the implantation members 20, or may
be removably attached thereto in a conventional manner. Member 50
may be rigid or flexible. Member 50 will have a sufficient surface
area to effectively retain a tissue-engineered matrix in place on a
bone or other body surface. Preferably, connecting member 50 will
have a circular cross-section, but may have other geometric
cross-sections as well including elliptical, polygonal, square,
rectangular, combinations thereof and the like. Member 50 may be
rigid or flexible, and may have a single filamentary structure or
have multiple interconnected filaments or members.
[0054] Referring now to FIGS. 3-8, the use of the graft fixation
devices 10 of the present invention in a surgical procedure is
illustrated. Referring first to FIG. 3, the initial step, prior to
the installation of a matrix containing a tissue-engineered tissue
using a graft fixation device 10 of the present invention, is to
drill or "tap " two bore holes 200 into a bone 210, for example,
subchondral bone in the knee joint. The bore holes 200 are seen to
be cylindrical holes having a bottom 208 and an open top 202 and
side walls 205. Optionally, the bore holes may be bone tunnels with
a continuous passage and no bottom, or an open bottom. It is
particularly preferred to tap the holes in the bone by using an
instrument 400 as illustrated in FIG. 10 which has a proximal
section conventionally referred to in this art as a "slap hammer"
section. The term "tapping" or "tap" as used herein is defined to
mean a procedure wherein the distal pointed prongs 420 extending
from the distal end 415 of the shaft 405 of instrument 400 are
located over a bone site, and the proximal end 410 of instrument
400 is tapped or hit with slidable hammer handle 450 (of the "slap
hammer"), which slides on shaft 460 between proximal end 410 and
proximal stop 470, to form the bone bore holes 200. The distal end
465 of shaft 460 is connected to proximal end 411. Proximal stop
470 is mounted to proximal end 467. Hammer handle 450 is seen to
have grasping section 451, collars 455 and longitudinal passage
457. Those skilled in the art will appreciate that a similar
pointed instrument may be used to "tap" in the bore holes into
bone, that is, any instrument having a nail-like distal end. In
addition, although not preferred, one bone bore hole at a time may
be "apped" in. If the surgeon decides to drill the bore holes into
bone, any conventional surgical drilling apparatus may be used.
After the bore holes 200 are formed into the bone 210, the matrix
220 containing tissue-engineering tissue is placed upon the bone
surface 201 by the surgeon as seen in FIG. 4. Next, the graft
fixation device 10 is mounted on to the insertion instrument 250.
Insertion instrument 250, as illustrated in FIG. 11, is seen to be
an elongated rod 260 having a proximal end 262 and a distal end
264. Mounted to the distal end 264 of the rod 260 is the depth stop
290. The depth stop 290 is seen to be a substantially rectangular
member which is mounted perpendicular to the longitudinal axis 251
of the rod 260. Depth stop 290 is seen to have bottom 292.
Extending distally from the bottom 292 of plate member 290 is a
pair of parallel, spaced-apart, mounting prongs 270. The mounting
prongs 270 are seen to be substantially rod-like members having
distal pointed tips 277 and proximal ends 272. The prongs 270 are
seen to have first section 273 and distal section 275. Section 273
is seen to have a greater cross-sectional dimension than distal
section 275 such that the entire section 275 is insertable into
passages 35 of members 20, while proximal section 273 is not
insertable therein. Instrument 250 is also seen to have a "slap
hammer section" consisting of proximal shaft 300 extending from
proximal end 262, slidable hammer handle 320 (the "slap hammer")
which is slidable upon shaft 300 between proximal end 262, and
proximal stop 330. Hammer handle member 320 is seen to have
grasping section 325, end collars 327 and longitudinal passage 329.
The graft fixation device 10 is mounted to the insertion instrument
250 by sliding the implantation members 20 onto the prongs 270 such
that the distal sections 275 of members 270 are engaged within the
longitudinal passages 35 of members 20 and distal points 277
protrude beyond the end of distal endface surfaces 37. Then, as
seen in FIGS. 5 and 6, the instrument 250 is manipulated such that
the graft fixation device 10 is inserted through matrix 220 and
into bone 210 by moving the implantation members 20 mounted on
prongs 270 into the bore holes 200 such that the members 20 are
engaged in the bore holes 200, and such that the tissue engagement
section 55 of the retention member 50 engages the matrix 220 such
that the matrix 220 is firmly engaged against the surface 201 of
the bone 210. If desired, holes may be cut into matrix 220 prior to
insertion of device 10. Then, as seen in FIG. 7, the insertion
instrument 250 is withdrawn proximally causing the prongs 270 to be
withdrawn from the passages 35 of the implantation members 20,
thereby leaving the graft fixation device 10 engaged in the bone
bore holes, and causing the matrix 220 to be maintained in
engagement with the surface 201 of bone 210. The "slap hammer"
section of instrument 250 may assist in removal of the prongs. A
cross-sectional view illustrating the device 10 engaged in bone 210
while maintaining the matrix 220 on bone surface 201 is seen in
FIG. 8.
[0055] FIG. 12 illustrates a matrix 220 mounted to bone surface 201
of bone 210 having multiple fixation devices of the present
invention installed to secure the matrix 220. The number,
anatomical location and orientation of fixation devices 10
necessary to provide sufficiently effective fixation will vary with
the size and type of implant or matrix, the type of tissue, the age
of the patient, the size of the patient's defect, the size of the
fixation devices, the material of construction of the fixation
devices, the load on the tissue at the repair site, etc.
[0056] Those skilled in the art will appreciate that the size of
the fixation devices of the present invention will vary in
accordance with a number of variables including the specific design
of the device, the materials of construction, the specific
application for the devices, the type of surgical procedure, etc.
Similarly, the size of the matrices fixated with these devices will
similarly vary. The Figures which are part of this specification
are merely schematic and illustrative of the device and method of
the present invention; the actual dimensions of the devices and
matrices may vary in practice.
[0057] The following example is illustrative of the principles and
practice of the present invention although not limited thereto.
EXAMPLE
[0058] Six sheep were prepared for a surgical procedure using
standard aseptic surgical techniques including the use of fully
sterilized instruments and equipment, and conventional anesthesia
procedures and protocols. The surgeon then created 7 mm diameter
chondral (full thickness cartilage) defects on a weight-bearing
area of the medial femoral condyle and in the trochlear groove in
the right stifle (knee) in each of the six skeletally mature sheep.
Defects were created using a specialized drill with a depth-stop to
prevent subchondral bone exposure or penetration. The base surfaces
of all the defects were then microfractured with a specialized
micropick tool to provide access for cellular migration. The
subjects were then separated into three groups of two subjects
each:
[0059] Group 1: defect filled with a collagen matrix, fixed with
the graft fixation device of the present invention.
[0060] Group 2: defect filled with a collagen matrix, fixed with
9-0 absorbable Vicryl.TM. suture (interrupted stitch technique,
approximately 12 strands per matrix).
[0061] Group 3: unfilled defect (control group).
[0062] Both defects in a given stifle received the same treatment
or served as controls.
[0063] For the two sheep in Group 1, after a defect had been
created and microfractured, a punch tool 400 was used to create the
two requisite bore holes in the subchondral bone to receive one
graft fixation device of the present invention. Only one
polydioxanone device (4mm tip-to-tip distance) was used to attach
each matrix. To create the bore holes, the punch tool was centered
in the defect, oriented in the sagittal plane, and hit or "tapped"
with a slap hammer repeatedly until it penetrated several
millimeters into the subchondral bone. Next, a 7mm diameter
circular collagen matrix, saturated with saline, was placed in the
defect and then blotted dry to remove excess saline. When the
inserter tool 250 was loaded with the graft fixation device 10 of
the present invention, the device and inserter tool were centered
above the matrix and oriented in the sagittal plane. The surgeon
then located the previously created bore holes by slowly advancing
the distal tips of the inserter through the matrix. Once the
surgeon located the holes with the inserter tips, a hammer was used
to fully advance the inserter tool (and implantation members 20 of
the fixation device 10) through the matrix and into the subchondral
bone. The inserter tool had a depth stop to prevent the
implantation members 20 from being inserted too deeply, thereby
assuring the proper placement of the implantation members through
the matrix. The insertion was completed when the connecting
retention member between the two implantation members initially
started to compress the collagen matrix, thereby indicating secure
fixation with the underlying subchondral bone. After the two
defects in a given stifle had each been repaired with a matrix and
fixation device, the stifle was closed and the sheep was allowed to
recover. It was noted by the surgeon that it took approximately one
minute to attach a matrix with a fixation device of the present
invention (Group 1), versus approximately 15 minutes to attach a
matrix with suture alone and the requisite suture manipulation and
knot tying (Group 2).
[0064] Two weeks after the surgeries were completed, the knee
joints were surgically opened for examination. Gross macroscopic
assessment of the joints demonstrated that all four matrices held
by the graft fixation device of the present invention were fully
intact. However, all four matrices held by sutures alone were only
partially intact with, on average, approximately 30% of the sutures
broken on any given matrix.
[0065] Another embodiment of the fixation device of the present
invention having multiple retention members is seen in FIG. 9. The
device 300 is seen to have a pair of implantation members 310. The
implantation members 310 are substantially cylindrical members
having longitudinal axis 311, distal ends 314 and proximal ends
312. Each implantation member 310 is seen to have a longitudinal
passage 320. The members 310 are seen to have a distal
frustoconical end 330, outer surface 350, and ridges 355 extending
outward from surface 350. The members 310 are seen to be connected
by a pair of retention members 340, having first and second ends
342 and 344 respectively.
[0066] Yet another embodiment of a fixation device of the present
invention is illustrated in FIGS. 13-17. The graft fixation device
500 is seen to have implantation members 520. The implantation
members 520 are seen to be elongated members, preferably having a
substantially cylindrical shape. The members 520 may have other
geometric shapes including conical, pyramidal, polygonal, cubic,
spherical, etc. The implantation members 520 are seen to have
distal ends 522 and proximal ends 524. Each implantation member 520
is seen to have an outer surface 528 and a longitudinal axis 529.
Each member 520 is also seen to have longitudinal passage 535
extending therethrough. The implantation members 520 are also seen
to have optional frustoconical ends 530, and proximal end face
surfaces 532. Although it is preferred that endface surfaces 532 be
flat, endface surfaces 532 may also be angled, concave, convex,
etc. Each endface surface 532 is seen to have central circular
opening 536 in communication with passage 535. Preferably, central
opening 536 will have a circular cross-section, but it may have
other geometric cross-sections as well including elliptical,
polygonal, square, rectangular, combinations thereof and the like.
Members 520 are also seen to have distal end face surfaces 537
having circular openings 538 in communication with passages 535.
Preferably, endface surfaces 537 have a sharp edge configuration,
but may also have various widths with a rounded or flat
configuration. As shown with the optional frustoconical end 530,
the annular end face surface 537 is of de minimis thickness around
opening 538, however this thickness would typically increase in the
absence of a frustoconical end. However, although not preferred,
even with a frustoconical, the end surface 537 could have various
widths as previously mentioned. Also seen to extend out from the
surface 528 of member 520 are a series of optional projections 540
having tissue engagement edges 544. Without the projections 540,
the surface 528 of the member 520 will be smooth, however, it will
be appreciated that surface 528 could be rough, or could have a
variety of conventional projections such as cones, hemispheres,
rods, hooks, etc., and the like and equivalents thereof.
[0067] The device 500 is seen to have graft retention member 550
connecting the implantation members 520. Retention member 550 is
seen to be a band-like member preferably having an oval
cross-section. The retention member 550 is seen to have first end
552, second end 554 and central section 555. First end 552 is seen
to extend up from proximal endface surface 532 of the first member
520 while end 554 is seen to extend up from the proximal endface
surface 532 of the other member 520. A section 557 of end 552 is
seen to extend out from section 539 of surface 528, while section
558 of second end 554 is also seen to extend out from a section 539
of surface 528. The ends 554 and 552 of retention member 550 may if
desired extend from or be mounted to any section of outer surface
528. The connecting member 550 is seen to be preferably bent or
shaped into three segments including top segment 555 and leg
segments 556. The top segment 555 is seen to an arc shaped member,
and the leg segments 56 are seen to be preferably perpendicular to
surfaces 532. Although it is preferred that connecting member 550
have an inverted "U" configuration, the connecting member 50 may
have other geometric configurations including semicircular, arced,
curved, triangular, polygonal, V-shaped, and the like and
combinations thereof. The ends 552 and 554 of connecting member 550
may be permanently affixed to the implantation members 520, or may
be removably attached thereto in a variety of conventional manners,
for example, a ball and socket joint, a plug joint, etc. Member 550
may be rigid or flexible. Member 550 will have a sufficient surface
area to effectively retain a tissue-engineered matrix in place on a
bone or other body surface. Preferably, connecting member 550 will
have an oval cross-section, but may have other geometric
cross-sections as well including circular, elliptical, polygonal,
square, rectangular, combinations thereof and the like. Member 550
may be rigid or flexible, and may have a single filamentary
structure or have multiple interconnected filaments or members.
[0068] Another aspect of the present invention is a distal
insertion member (device) useful with the fixation devices of the
present invention. As seen in FIG. 18, the insertion device 600 is
seen to be a substantially cylindrical member having proximal end
610 and distal end 620. Proximal end 610 is seen to have a flat end
surface 612. Frustoconical end section 630 is seen to extend
distally from distal end 620, although device 600may have other
configurations as well. If desired, distal end 620 can have any
tapered or curved configuration, but it is preferred that it have a
frustoconical end section extending therefrom. The frustoconical
end section 630 is seen to have outer surface 632 and distal tip
640. The member 600 is also seen to have exterior surface 650.
Extending through member 600 is the longitudinal passage 660 having
first circular opening 665 in communication therewith, and second
circular opening 667 in tip 640 in communication therewith. The
insertion members 600 are used in combination with the fixation
members of the present invention to engage the fixation member in
bone simultaneously with tapping the bore holes into bone, thereby
eliminating the need for a separate step to form the bore holes
prior to inserting the fixation member.
[0069] Referring to FIGS. 1921, the previously mentioned
combination of an insertion member 600 and a fixation member 500 is
illustrated. Initially, a fixation member 500 is mounted to prongs
700 extending from the distal end 415 of the shaft 405 of
instrument 400. Each prong 700 is seen to have first cylindrical
section 710 extending from the distal end 415 of the shaft 405.
Each cylindrical section 710 is seen to have proximal end 711 and
distal end 712, and receiving grooves 715. Extending from the
distal end 712 of each first section 710 is the central pin section
720. Central pin section 720 is seen to have proximal end 722 and
distal end 724. Extending distally from distal end 724 of central
pin section 720 is the distal pin member 730. Distal pin member 730
is seen to have proximal end 732 and distal pointed end 734.
[0070] If desired, the insertion member 600 may be molded into or
affixed to the distal end of an implantation member 520, thereby
forming a unitary structure as seen in FIG. 31 and FIG. 32. In
addition, the insertion member 600 may be mounted to the distal end
of an implantation member 520 in a conventional manner by gluing,
cementing, mechanical fastening, friction fit and the like and
equivalents thereof.
[0071] The combination of the insertion members 600 and fixation
members, such as fixation member 500 of the present invention, are
used to affix a matrix to bone in the following manner. Initially,
the implantation members 520 of a fixation device 500 are placed
upon prongs 700 of an instrument 400 such that the leg members 556
are at least partially engaged in grooves 715 in first section 710
(see FIG. 21), and, intermediate sections 720 of pin members 700
are engaged in passages 535 of implantation members 520, while pin
members 730 extend out from the distal ends of the implantation
members 520. Then, insertion members 600 are placed over the pin
members 730, such that the pin members 730 are engaged in passages
660, and such that the pointed piercing ends 734 extend beyond the
distal ends 640 of the insertion member 660. Then, the tool 400 and
the assembly consisting of fixation device 500 and insertion member
600 is placed over a tissue matrix 220 placed upon a bone 210. The
piercing points are then pressed through matrix 220 to contact the
surface 211 of bone 210. A slap-hammer section of instrument 400 is
engaged to drive the piercing points 734, insertion members 600 and
implantation members 520 into the bone 210 as bore holes 200 are
formed in the bone. The instrument 400 is then withdrawn
proximately, thereby removing the intermediate sections 720 of
prongs 700 from the implantation members 520 and the pin members
730 from the insertion members 600, leaving the insertion members
600 and the implantation members 520 securely in the bone (as seen
in FIG. 20). This completes the affixation of the matrix 220 to the
bone 210 using a single step, wherein the bore holes in the bone
are formed simultaneously as insertion members 600 and fixation
device 500 are emplaced in the bone.
[0072] It is particularly preferred to use conventional remote
visualization surgical procedures when inserting the fixation
devices of the present invention. For example, inserting a scope
through a trocar cannula into the joint or body cavity, while
insufflating the joint or body cavity.
[0073] The insertion members 600 will typically be made from a
strong, hard, bioabsorbable material such that they can be driven
into bone without fracturing or breaking. Examples of the types of
materials which can be used to make the insertion member 600
include polylactic acid, polyglycolic acid, tricalcium phosphate,
calcium phosphate, tetracalcium phosphate and hydroxyapatite, and
any copolymers, mixtures or blends thereof. Although not preferred,
it is possible to make the insertion members from a conventional
biocompatible material which is not bioabsorbable or biodegradable,
such as titanium, stainless steel, ceramics, Nitinol and the like
and equivalents thereof. The insertion member 600 assists in
forming the bore holes 200 while protecting the implantation
members 520.
[0074] FIGS. 22-23 illustrate a disposable distal end assembly 800
for an instrument 400 of the present invention. When using the
disposable assembly 800, it is preferable that the distal end 415
of the shaft 405 of instrument 400 have screw threads 418, although
other conventional detachable mounts may be used, for example a
bayonet-type mount, locking levers and tabs, male and female mating
sections, etc. As seen in FIGS. 22-25, the assembly 800 consists of
housing 810 having proximal end 811 and distal end 817. Housing 810
is seen to have hollow cavity 815 therein. Cavity 815 is seen to be
in communication with proximal end opening 812 and distal end
openings 820. Member 810 is seen to have outer surface 822. Outer
surface 822 is preferably knurled to facilitate the grasping and
turning of the housing 810. Housing 810 is further seen to have
distal end surface 825. The outer surface 822 is seen to have a
tapered section 823 that tapers toward end face 825. Contained
within cavity 815, on inner surface 818 are the screw threads 819.
Assembly 800 is also seen to have driving pin members 830. Each
driving pin member 830 is seen to have proximal disk member 832
mounted to proximal end 831, shaft section 834 and distal pointed
end 838. Surrounding each opening 820 on the interior of the member
810 are the annular recesses 840. The assembly 800 is mounted to
the distal end 415 of the instrument 400 in the following manner.
The pins 830 are inserted into cavity 815 and through openings 820
such that the shafts 834 and distal piercing points 838 extend
through end face 825, and the disk members 832 are contained within
the annular recesses 840. Then, the housing 810 is mounted upon the
threads of distal end 415 such that threads 418 engage mating
threads 819, and screwed further such that the proximal end
surfaces 833 of the disk members 832 are in contact with the distal
end face 416 of distal end 415. After use in a surgical procedure,
the assembly 800 is removed and discarded. A new sterile assembly
800 is utilized with a cleaned and sterilized instrument 400 for
each new procedure.
[0075] Referring now to FIGS. 26-30, a disposable end assembly 900
for mounting to an insertion instrument 250 is illustrated. The
insertion member 250 is seen to have distal end 264, having endface
265 and screw threads 266. The assembly 900 is seen to have housing
950. Housing 950 has proximal end 952 and distal end 956 and
exterior surface 954. Extending from distal end 956 is the plate
member 960. Plate member 960 is seen to have distal surface 962.
The exterior surface 954 is seen to have optional knurling and
distal tapered section 957 tapering into plate member 960. Housing
950 is seen to have internal cavity 955. Housing 950 is also seen
to have proximal opening 951 in communication with cavity 955 and
distal openings 970 also in communication therewith. Housing 950 is
seen to have internal screw threads 959 extending from internal
surface 958. Also contained within the interior of housing 950 in
the distal end 956 is the recessed groove 980. Assembly 900 is
mounted to the distal end 264 of instrument 250 in the following
manner. Pins 910 are inserted through cavity 950 and openings 970
such that proximal members 922 are engaged in groove 980. Sections
920 and 930 of pins 910 extend through openings 970. Sections 920
are seen to have grooves 925. Then, the housing 950 is screwed on
to distal end 264 such that the threads 266 engage the mating
internal threads 959 of housing 950. The housing is tightened until
the distal end surface 265 of the distal end 264 engages the top
surfaces 923 of members 922. After a surgical procedure, the
assembly 900 is removed from instrument 250 and discarded. A new
sterile assembly 900 is utilized with a cleaned and sterilized
instrument 250 for each new procedure.
[0076] An alternate embodiment of the graft fixation devices of the
present invention is illustrated in FIGS. 33-37. Referring first to
FIGS. 33, 34 and 35, the graft fixation device 1000 is seen to have
implantation member 1020. The implantation member 1020 is seen to
be an elongated member, preferably having a substantially
cylindrical shape. The member 1020 may have other geometric shapes
including conical, pyramidal, polygonal, cubic, spherical, etc. The
implantation member 1020 is seen to have distal end 1022 and
proximal end 1024. The implantation member 1020 is also seen to
have an outer surface 1028 and a longitudinal axis 1029. The member
1020 is also seen to have longitudinal passage 1035 extending
therethrough. The implantation member 1020 is seen to have
truncated frustoconical end 1030, and proximal end face surface
1032. Although it is preferred that endface surface 1032 be flat,
endface surface 1032 may also be angled, concave, convex, etc. The
endface surface 1032 is seen to have central circular opening 1036
in communication with passage 1035. Preferably, central opening
1036 will have a circular cross-section, but it may have other
geometric cross-sections as well including elliptical, polygonal,
square, rectangular, combinations thereof and the like. Member 1020
is also seen to have distal end face surface 1037 having circular
opening 1038 in communication with passage 1035. Preferably,
endface surfaces 1037 have a sharp edge configuration when used
without an insertion member (although not shown), but may also have
various widths with a rounded or flat configuration. Also seen to
extend out from the surface 1028 of member 1020 are a series of
optional projections 1040 having tissue engagement edges 1044.
Without the projections 1040, the surface 1028 of the member 1020
will be smooth, however, it will be appreciated by those skilled in
the art that the surface 1028 could be rough, or could have a
variety of conventional projections such as cones, hemispheres,
rods, hooks, etc., and the like and equivalents thereof.
[0077] The device 1000 is seen to have graft retention members
1050. Retention members 1050 are seen to be elongated members
preferably having an oval cross-section. Retention member 1050 is
seen to have first end 1052, second free end 1054, first section
1055 and second section 1057. First end 1052 is seen to extend
proximally from proximal endface surface 1032 of member 1020.
Section 1057 is seen to be angulated with respect to section 1055
at angulation 1058. The second section 1057 is the graft contact or
retention element of the device 1000. If desired, the retention
member 1050 may extend up from any location on the member 1020.
preferably perpendicular to surfaces 1032.
[0078] Preferably, retention member 1050 will have an oval
cross-section, but may have other geometric cross-sections as well
including circular, elliptical, polygonal, square, rectangular,
combinations thereof and the like. Member 1050 may be rigid or
flexible, and may have a single filamentary structure or have
multiple interconnected filaments or members. Although it is
preferred to have two retention members 1050 mounted diagonally
across from each other, any number of retention members 1050 may be
utilized sufficient to effectively retain a graft. For example, the
device may have four retention members 1050 as seen in FIGS. 36 and
37. Or, the device may have a single retention member 1050 (not
shown).
[0079] Preferably, the device 1000 has an insertion device or
insertion member 1100 mounted to the distal end of member 1020. The
insertion member 1100 is seen to be a substantially cylindrical
member having proximal end 1110 and distal end 1120. Proximal end
1110 is seen to have a flat end surface 1112. Proximal end 1110 is
seen to have an irregular shape tapering from a first larger
diameter to a second smaller diameter to facilitate attachment to
the member 1020, however, proximal end 1110 may have a uniform
shape with a constant diameter. Frustoconical end section 1130 is
seen to extend distally from distal end 1120, although device 1100
may have other configurations as well. If desired, distal end 1120
can have any tapered or curved configuration, but it is preferred
that it have a frustoconical end section extending therefrom. The
frustoconical end section 1130 is seen to have outer surface 1132
and distal tip 1140. The member 1100 is also seen to have exterior
surface 1150. Extending through member 1100 is the longitudinal
passage 1160 having first circular opening 1165 in communication
therewith, and second circular opening 1167 in tip 1140 in
communication therewith. The insertion members 1100 are used in
combination with the implantation members 1020 to engage the
fixation member 1000 in bone simultaneously with tapping the bore
holes into bone, thereby eliminating the need for a separate step
to form the bore holes prior to inserting the fixation member
1000.
[0080] The members 1160 are preferably mounted to implantation
members 1020 by using conventional methods including insert
molding, injection molding, press fitting, adhesives, glue and the
like and combinations thereof, although the devices 1160 may be
used in combination with an implantation member 1020 without
mounting it to the implantation member 1020. The devices 1000,
including implantation member 1050 and insertion devices 1060 are
preferably made from the materials listed hereinabove and the like.
The devices 1000 are implanted in bone to retain grafts in a manner
similar to that as previously described above for devices having
multiple implantation members, using similar insertion instruments
suitably modified to insert a device with a single implantation
member.
[0081] The fixation devices of the present invention and the
combination of the fixation devices with insertion members, and
methods of using such devices and combinations, of the present
invention have many advantages. The advantages include providing a
fast and routine way to fixate a matrix of tissue engineered tissue
or other tissue. The fixation devices and combination, because they
eliminate the need for suture knot tying, can be utilized in
arthroscopic surgical procedures that require a minimum of surgical
incisions and thus greatly reduce patient morbidity. In addition,
the fixation devices and combination have been demonstrated to
provide excellent matrix fixation without damaging the surrounding
normal cartilaginous tissue, unlike the conventional fixation of
chondral defect matrices with traditional suture that must be
passed through (and thus damage) the surrounding tissue.
[0082] Although this invention has been shown and described with
respect to detailed embodiments thereof, it will be understood by
those skilled in the art that various changes in form and detail
may be made without departing from the spirit and scope of the
claimed invention.
* * * * *